Premium
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | Mr. William Mark WatsonLead Independent Director | 10,00k | 6,53k | Achat | 0,65 | 118,13k | 9,25% |
| 2026-05-19 | Mr. Jeroen GrasmanCFO, Principal Accounting Officer & Principal Financial Officer | -31,40k | 19,15k | Sale to Issuer | 0,61 | 545,61k | -5,44% |
| 2026-03-28 | Dr. Sean N. TuckerSenior VP & Chief Scientific Officer | -3,92k | 2,55k | Sale to Issuer | 0,65 | 371,34k | -1,05% |
| 2026-03-28 | Dr. James F. CummingsChief Medical Officer | -3,29k | 2,14k | Sale to Issuer | 0,65 | 325,18k | -1,00% |
| 2026-03-24 | Mr. Edward B. BergSenior VP & General Counsel | -36,42k | 25,27k | Sale to Issuer | 0,69 | 268,37k | -11,95% |
| 2026-03-24 | Mr. Steven LoPresident, CEO & Director | -126,03k | 87,46k | Sale to Issuer | 0,69 | 560,36k | -18,36% |
| 2026-03-24 | Dr. Sean N. TuckerSenior VP & Chief Scientific Officer | -36,42k | 25,27k | Sale to Issuer | 0,69 | 364,32k | -9,09% |
| 2026-03-24 | Dr. James F. CummingsChief Medical Officer | -30,55k | 21,20k | Sale to Issuer | 0,69 | 317,53k | -8,78% |
| 2026-03-18 | Mr. Edward B. BergSenior VP & General Counsel | -8,07k | 5,12k | Sale to Issuer | 0,63 | 791,79k | -1,01% |
| 2026-03-18 | Dr. James F. CummingsChief Medical Officer | -6,77k | 4,30k | Sale to Issuer | 0,63 | 246,58k | -2,67% |
| 2026-03-18 | Mr. Steven LoPresident, CEO & Director | -22,43k | 14,23k | Sale to Issuer | 0,63 | 335,13k | -6,27% |
| 2026-03-18 | Dr. Sean N. TuckerSenior VP & Chief Scientific Officer | -8,07k | 5,12k | Sale to Issuer | 0,63 | 299,24k | -2,63% |
| 2026-02-02 | Mr. Edward B. BergSenior VP & General Counsel | -9,27k | 5,64k | Sale to Issuer | 0,61 | 188,86k | -4,68% |
| 2026-02-02 | Dr. James F. CummingsChief Medical Officer | -7,97k | 4,85k | Sale to Issuer | 0,61 | 230,86k | -3,34% |
| 2026-02-02 | Dr. Sean N. TuckerSenior VP & Chief Scientific Officer | -9,27k | 5,64k | Sale to Issuer | 0,61 | 284,81k | -3,15% |
| 2025-12-04 | Mr. Steven LoPresident, CEO & Director | -54,15k | 20,04k | Sale to Issuer | 0,37 | 295,06k | -15,51% |
| 2025-11-17 | Mr. William Mark WatsonLead Independent Director | 20,00k | 8,19k | Achat | 0,41 | 108,13k | 22,70% |
| 2025-11-17 | Dr. Elaine J. HeronIndependent Director | 40,00k | 15,92k | Achat | 0,39 - 0,41 | 80,57k | 98,60% |
| 2025-07-17 | Mr. Kevin P. FinneyIndependent Director | 116,67k | 44,43k | Achat | 0,37 - 0,40 | 166,67k | 233,34% |
| 2025-08-15 | Mr. Kevin P. FinneyIndependent Director | 50,00k | 17,50k | Achat | 0,35 | 166,67k | 42,86% |
| 2025-07-29 | Mr. William Mark WatsonLead Independent Director | 10,00k | 4,05k | Achat | 0,41 | 83,21k | 13,66% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
